Antitumor activity of the bioreductive prodrug 3-(2-nitrophenyl) propionic acid-paclitaxel nanoparticles (NPPA-PTX NPs) on MDA-MB-231 cells: in vitro and in vivo

Antitumor activity of the bioreductive prodrug 3-(2-nitrophenyl) propionic acid-paclitaxel nanoparticles (NPPA-PTX NPs) on MDA-MB-231 cells: in vitro and in vivo

Xiao-Chuan Duan,1,2,* Xin Yao,1,2,* Shuang Zhang,1,2 Mei-Qi Xu,1,2 Yan-Li Hao,1,2 Zhan-Tao Li,1,2 Xiu-Chai Zheng,2 Man Liu,1,2 Zhuo-Yue Li,1,2 Hui Li,1 Jing-Ru Wang,1,2 Zhen-Han Feng,1 Xuan Zhang1,2 1Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmace...

Full description

Bibliographic Details
Main Authors: Duan X, Yao X, Zhang S, Xu M, Hao Y, Li Z, Zheng X, Liu M, Li H, Wang J, Feng Z, Zhang X
Format: Article
Language:English
Published: Dove Medical Press 2018-12-01
Series:International Journal of Nanomedicine
Subjects:
bioreductive prodrug
3-(2-nitrophenyl) propionic acid paclitaxel (NPPA-PTX)
nanoparticles
antitumor activity
in vitro and in vivo.
Online Access:https://www.dovepress.com/antitumor-activity-of-the-bioreductive-prodrug-3-2-nitrophenyl-propion-peer-reviewed-article-IJN

Internet

https://www.dovepress.com/antitumor-activity-of-the-bioreductive-prodrug-3-2-nitrophenyl-propion-peer-reviewed-article-IJN

Similar Items